Treatment of autonomic neuropathy, postural tachycardia and orthostatic syncope with octreotide LAR

Clinical Autonomic Research

Volumn 17, Issue 6, 2007, Pages 334-340

  Hoeldtke, Robert D ^a   Bryner, Kimberly D ^a   Hoeldtke, Martin E ^a   Hobbs, Gerald ^b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Autonomic nervous system; Midodrine; Octreotide; Postural tachycardia

Indexed keywords

LONG ACTING DRUG; OCTREOTIDE;

ADULT; AGED; ARTICLE; AUTONOMIC NEUROPATHY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BODY POSTURE; CHRONIC DRUG ADMINISTRATION; CHRONIC FATIGUE SYNDROME; CLINICAL TRIAL; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFECT; FEMALE; HEART BEAT; HEART RATE; HEMODYNAMICS; HUMAN; MALE; OPEN STUDY; ORTHOSTATIC HYPOTENSION; PATIENT COMPLIANCE; PILOT STUDY; PRESSOR RESPONSE; SITTING; STATISTICAL SIGNIFICANCE; SUPINE POSITION; SYNCOPE; TACHYCARDIA; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; AUTONOMIC NERVOUS SYSTEM; AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD PRESSURE; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; HYPOTENSION, ORTHOSTATIC; MALE; MIDDLE AGED; OCTREOTIDE; POSTURE; SYNCOPE; SYNDROME; TACHYCARDIA;

EID: 37249079205     PISSN: 09599851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10286-007-0436-x     Document Type: Article

References (15)

1. Benrud-Larson LM, Dewar MS, Sandroni P, Rummans TA, Haythornthwaite JA, Low PA (2002) Quality of life in patients with postural tachycardia syndrome. Mayo Clin Proc 77:531-537
2. Escorsell A, Bandi JC, Andreu V, Moitinho E, Garcia-Pagan JC, Bosch J, Rodes J (2001) Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology 120:161-169
3. Fukuda K, Straus SE, Hickie I, Sharpe M, Dobbins JG, Komaroff A, for the International Chronic Fatigue Syndrome Study Group (1994) Chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 121:953-959
4. Hoeldtke RD, D'Dorisio TM, Boden G (1987) Treatment of autonomic neuropathy with a somatostatin analogue. Lancet II 602-605
5. Hoeldtke RD, David KM (1991) Orthostatic tachycardia syndrome: evaluation of autonomic function and treatment with octreotide and ergot alkaloids. J Clin Endo Metab 73:132-139
6. Hoeldtke RD, Horvath GG, Bryner KD, Hobbs GR (1998) Treatment of orthostatic hypotension with midodrine and octreotide. J Clin Endo Metab 83:339-343
7. Hoeldtke RD, Bryner KD, Hoeldtke M, Hobbs G (2006) Treatment of postural tachycardia syndrome: a comparison of octreotide and midodrine. Clin Auton Res 16:390-395
8. Low PA, Gilden JL, Freeman R, Sheng K, McElligott MA (1997) Midodrine study group. Efficacy of midodrine vs. placebo in neurogenic orthostatic hypotension. JAMA 277:1046-1051
9. Pop-Busui R, Chey W, Stevens MS (2000) Severe hypertension induced by the long-acting somatostatin analogue sandostatin LAR in a patient with diabetic autonomic neuropathy. J Clin Endo Metab 85:943-946
10. Singer W, Sandroni P, Opfer-Gehrking TL, Suarez GA, Klein GM, Hines S, O'Brien PC, Slezak J, Low PA (2006) Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol 63:513-518
11. Sizer K (1999) Sandostatin LAR depot investigator's brochure, Novartis Pharmaceuticals, Basel Switzerland, p 32
12. Stewart JM, McLeod KJ, Sanyal S, Herzberg G, Montgomery LD (2004) Relation of postural vasovagal syncope to splanchnic hypervolemia in adolescents. Circulation 100:2675
13. Stewart JM, Medow MS, Glover JL, Montgomery L (2006) Persistent splanchnic hyperemia during upright tilt in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol 290:H665-H673
14. Streeten DHP, Anderson GH (1992) Delayed orthostatic intolerance. Arch Intern Med 152:1066-1072
15. Winer BJ (1979) Statistical principles and experimental design. 2nd ed. McGraw Hill, New York pp 309-603